"As the pharmaceutical and biotech industries work to enhance relationships with key customers in the payer space, they have opted to increase the number of skilled liaisons to interact with decision makers," Berg-Henne said.
"The increase in health outcomes focus isn't much of a surprise to our firm," Berg-Henne continued. "We have been monitoring the commercial operations landscape within the pharmaceutical industry for more than 20 years. We knew payers were under great pressure to control costs as they consider different treatment options; this only confirms what we already assumed."
Berg-Henne also explained how many pharmaceutical companies attempt to leverage these expensive assets to the fullest extent. Several of the companies studied utilize highly experienced HEOR liaisons to cover multiple therapeutic areas of interest, rather than having them concentrate on a specific disease state.
PharmaForce International is a competitive intelligence firm with over two decades of experience in the pharmaceutical and biotech industries, they have become the market leader in commercial operations benchmarking and competitive intelligence. Globally focused, they have the competencies to perform the research required by clients in most of the major pharmaceutical markets in the world including Latin America, Europe, Japan, and the United States.
For more information on the report mentioned above, please contact Lorrie Berg-Henne at email@example.com or by phone at 610-370-2906.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pharmaforce-international-us-heor-personnel-deployed-in-a-field-capacity-increased-by-more-than-50-300407080.html
SOURCE PharmaForce International